Dr David T Dang, DDS in La Puenta, CA - Dentist

Dr David T Dang, DDS is a Dentist based in La Puenta, California. Dr David T Dang is licensed to practice in California (license number 52975) and his current practice location is 1419 North Hacienda Blvd, La Puenta, California. He can be reached at his office (for appointments etc.) via phone at (626) 917-5830.

NPI number for Dr David T Dang is 1295842441 and his current mailing address is 1419 North Hacienda Blvd, La Puenta, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1295842441.

Contact Information

	Dr David T Dang, DDS
	1419 North Hacienda Blvd, La Puenta, CA 91744
	(626) 917-5830
	(626) 918-3538

Healthcare Provider's Profile

Full Name	Dr David T Dang
Gender	Male
Speciality	Dentist
Location	1419 North Hacienda Blvd, La Puenta, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1295842441
Provider Enumeration Date: 08/24/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr David T Dang such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295842441	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
122300000X	Dentist	52975 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr David T Dang is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr David T Dang, DDS 1419 North Hacienda Blvd, La Puenta, CA 91744 Ph: (626) 917-5830	Dr David T Dang, DDS 1419 North Hacienda Blvd, La Puenta, CA 91744 Ph: (626) 917-5830

News Archive

Montreal Heart Institute and Cerenis commence CER-001 Phase 2 study in acute coronary syndrome

The Montreal Heart Institute today announced the start of the Phase 2 CHI-SQUARE (Can HDL Infusions Significantly QUicken Atherosclerosis REgression?) study of CER-001 in patients with acute coronary syndrome (ACS), in collaboration with Cerenis Therapeutics, a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and metabolic diseases.

Light-powered nanomachine kills cancer cells

Researchers from the Nano Machine Center at the California NanoSystems Institute at UCLA have developed a novel type of nanomachine that can capture and store anticancer drugs inside tiny pores and release them into cancer cells in response to light.

China recruits foreign companies, community-based groups, trade unions to join fight against HIV/AIDS

Chinese officials have begun enlisting international companies, community-based organizations and trade unions to join the fight against HIV/AIDS in the country, the Los Angeles Times reports.

Virgin HealthMiles' Pay-for-Prevention approach aims to reduce U.S. obesity rates

Today, Virgin HealthMiles, a provider of incentives-based health and productivity programs for business and government, lent its support to the newly-launched Healthy Weight Commitment Foundation, which aims to help reduce U.S. obesity rates by increasing access and opportunities for physical activity, healthier nutrition options and raising awareness of the energy balance approach - in the marketplace, in the workplace and in schools.

Dr David T Dang, DDS - Dentist in La Puenta, CA